Establishment of HIV-1 latency in resting CD4⁺ T cells depends on chemokine-induced changes in the actin cytoskeleton

Eradication of HIV-1 with highly active antiretroviral therapy (HAART) is not possible due to the persistence of long-lived, latently infected resting memory CD4⁺ T cells. We now show that HIV-1 latency can be established in resting CD4⁺ T cells infected with HIV-1 after exposure to ligands for CCR7...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 107; no. 39; pp. 16934 - 16939
Main Authors Cameron, Paul U, Saleh, Suha, Sallmann, Georgina, Solomon, Ajantha, Wightman, Fiona, Evans, Vanessa A, Boucher, Genevieve, Haddad, Elias K, Sekaly, Rafick-Pierre, Harman, Andrew N, Anderson, Jenny L, Jones, Kate L, Mak, Johnson, Cunningham, Anthony L, Jaworowski, Anthony, Lewin, Sharon R
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 28.09.2010
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Eradication of HIV-1 with highly active antiretroviral therapy (HAART) is not possible due to the persistence of long-lived, latently infected resting memory CD4⁺ T cells. We now show that HIV-1 latency can be established in resting CD4⁺ T cells infected with HIV-1 after exposure to ligands for CCR7 (CCL19), CXCR3 (CXCL9 and CXCL10), and CCR6 (CCL20) but not in unactivated CD4⁺ T cells. The mechanism did not involve cell activation or significant changes in gene expression, but was associated with rapid dephosphorylation of cofilin and changes in filamentous actin. Incubation with chemokine before infection led to efficient HIV-1 nuclear localization and integration and this was inhibited by the actin stabilizer jasplakinolide. We propose a unique pathway for establishment of latency by direct HIV-1 infection of resting CD4⁺ T cells during normal chemokine-directed recirculation of CD4⁺ T cells between blood and tissue.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Author contributions: P.U.C., A.J., and S.R.L. designed research; S.S., G.S., A.S., F.W., V.A.E., G.B., A.N.H., J.L.A., and K.L.J. performed research; P.U.C., S.S., G.S., G.B., E.K.H., R.-P.S., A.N.H., J.L.A., J.M., A.L.C., A.J., and S.R.L. analyzed data; and P.U.C., S.S., and S.R.L. wrote the paper.
Edited by Malcolm A. Martin, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved August 23, 2010 (received for review March 8, 2010)
1P.U.C. and S.S. contributed equally to this work.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1002894107